STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] Henry Schein Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

This Amendment No. 4 to the Schedule 13D reports that a group of KKR-related entities and individuals beneficially own 17,583,918 shares of Henry Schein, Inc. common stock, representing approximately 14.5% of the company's outstanding common stock based on 121,268,398 shares outstanding as of July 28, 2025. The reported holdings comprise 15,263,662 shares held directly by KKR Hawaii Holdings L.P., 1,931,886 shares KKR Hawaii Aggregator L.P. has the right to acquire under total return swaps (including a disclosed August Swap), and 388,370 shares held by MH Sub I, LLC.

The filing discloses that on August 6, 2025 KKR Hawaii Aggregator L.P. entered an August Swap covering 1,874,538 notional shares at an initial notional price of $66.19 per share. In connection with a Margin Loan Agreement dated August 14, 2025, KKR Hawaii Holdings L.P. borrowed $300,000,000, pledged 15,263,662 shares as collateral, and the loan is expected to mature around August 14, 2028. KKR entities executed joinder and registration-rights agreements related to those holdings. The Schedule 13D remains otherwise unchanged except as amended.

Positive

  • Significant disclosed stake: Reporting Persons beneficially own 17,583,918 shares (≈14.5%) of HSIC, a material ownership position.
  • Clear transparency: Amendment discloses both direct holdings and derivative exposure including the August Swap notional and price.
  • Registration and governance steps: Joinder to Partnership and Registration Rights Agreements was executed, clarifying holder rights and obligations.

Negative

  • Pledged collateral under leverage: 15,263,662 shares are pledged to secure a $300,000,000 margin loan, creating potential for lender enforcement and share disposition.
  • Derivative exposure: 1,931,886 shares of economic exposure arise from swaps (including 1,874,538 notional in the August Swap), adding counterparty and settlement risk.
  • Potential supply overhang: Lender rights upon customary loan events could increase sell-side pressure on HSIC shares.

Insights

TL;DR: KKR-affiliated investors now report a sizable 14.5% economic and voting stake in HSIC, using swaps and pledged collateral with a $300M margin loan.

The disclosed 14.5% beneficial ownership is material for shareholders and could influence corporate dynamics given the ownership concentration. The combination of direct holdings (15.26M shares) and derivative exposure (1.93M shares via swaps) signals economic exposure beyond outright stock positions. The filing quantifies swaps (August Swap: 1,874,538 notional at $66.19) and confirms a significant margin facility ($300 million) secured by 15,263,662 pledged shares. These facts are important for modeling potential supply overhang, dilution of voting alignment if lenders foreclose, and for assessing whether KKR may seek influence or strategic outcomes at the issuer level.

TL;DR: Material counterparty, leverage and collateral arrangements create execution and liquidation risk for HSIC shares held by the reporting group.

The Margin Loan Agreement creates a pathway for lenders to sell the pledged 15.26M shares upon customary loan events, which could pressure the stock if exercised. Use of total return swaps concentrates counterparty exposure to Nomura for 1.87M notional shares; settlement or price-movement triggers could alter reported beneficial ownership and market liquidity. While the filing disclaims admissions of beneficial ownership by certain affiliates, the documented pledge, loan maturity (circa August 14, 2028), and derivatives positions are clear operational risks that investors and governance stakeholders should note.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


KKR Hawaii Holdings L.P.
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Assistant Secretary, KKR Hawaii Holdings GP LLC, its general partner
Date:08/15/2025
KKR Hawaii Holdings GP LLC
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Assistant Secretary
Date:08/15/2025
KKR Hawaii Aggregator L.P.
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Assistant Secretary, KKR Hawaii Aggregator GP LLC, its general partner
Date:08/15/2025
KKR Hawaii Aggregator GP LLC
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Assistant Secretary
Date:08/15/2025
KKR North America Fund XIII SCSp
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Authorized Signatory, KKR North America XIII S.a r.l., GP of KKR Associates North America XIII SCSp, its general partner
Date:08/15/2025
KKR Associates North America XIII SCSp
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Authorized Signatory, KKR North America XIII S.a r.l., its general partner
Date:08/15/2025
KKR North America XIII S.a r.l.
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Authorized Signatory
Date:08/15/2025
KKR North America XIII Holdings Limited
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Assistant Secretary
Date:08/15/2025
MH Sub I, LLC
Signature:/s/ B. Lynn Walsh
Name/Title:B. Lynn Walsh, Secretary
Date:08/15/2025
Indigo Intermediate Co II, LLC
Signature:/s/ B. Lynn Walsh
Name/Title:B. Lynn Walsh, Secretary
Date:08/15/2025
IB Aggregator II L.P.
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Assistant Secretary, KKR Indigo Aggregator III GP LLC, its controlling general partner
Date:08/15/2025
KKR Indigo Aggregator III GP LLC
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Assistant Secretary
Date:08/15/2025
KKR Americas Fund XII (Indigo) L.P.
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Assistant Secretary, KKR Americas XII AIV GP LLC, GP of KKR Associates Americas XII AIV L.P., its general partner
Date:08/15/2025
KKR Associates Americas XII AIV L.P.
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Assistant Secretary, KKR Americas XII AIV GP LLC, its general partner
Date:08/15/2025
KKR Americas XII AIV GP LLC
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Assistant Secretary
Date:08/15/2025
KKR Group Partnership L.P.
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Secretary, KKR Group Holdings Corp., its general partner
Date:08/15/2025
KKR Group Holdings Corp.
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Secretary
Date:08/15/2025
KKR Group Co. Inc.
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Secretary
Date:08/15/2025
KKR & Co. Inc.
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Secretary
Date:08/15/2025
KKR Management LLP
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Assistant Secretary
Date:08/15/2025
Henry R. Kravis
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Attorney-in-fact
Date:08/15/2025
George R. Roberts
Signature:/s/ Christopher Lee
Name/Title:Christopher Lee, Attorney-in-fact
Date:08/15/2025

FAQ

How many HSIC shares do the KKR-related Reporting Persons beneficially own?

The Reporting Persons beneficially own 17,583,918 shares, representing approximately 14.5% of HSIC common stock based on 121,268,398 shares outstanding.

What derivative positions are disclosed in the HSIC Schedule 13D/A?

The filing discloses total return swaps including an August Swap covering 1,874,538 notional shares with a notional price of $66.19 per share; aggregate swap-based rights to acquire amount to 1,931,886 shares.

What leverage is associated with the KKR holdings in HSIC?

KKR Hawaii Holdings L.P. borrowed an aggregate of $300,000,000 under a Margin Loan Agreement dated August 14, 2025, secured by a pledge of 15,263,662 shares of HSIC.

When does the disclosed margin loan mature?

The loans under the Margin Loan Agreement are expected to mature on or about August 14, 2028.

Does the filing show that KKR intends to take control of HSIC?

The Schedule 13D/A amends prior disclosures to report holdings, swaps, a margin loan and related agreements but does not state any intent to acquire control; it also states the filing should not be construed as an admission of beneficial ownership by certain affiliates.
Henry Schein

NASDAQ:HSIC

HSIC Rankings

HSIC Latest News

HSIC Latest SEC Filings

HSIC Stock Data

8.89B
100.85M
0.87%
114.26%
7.09%
Medical Distribution
Wholesale-medical, Dental & Hospital Equipment & Supplies
Link
United States
MELVILLE